搜索临床试验以:CTT1057
总计23个结果
-
Cancer Targeted TechnologyUniversity of California, San Francisco完全的
-
Cancer Targeted TechnologyUniversity of California, San Francisco完全的
-
Novartis Pharmaceuticals完全的
-
National Institute of Allergy and Infectious Diseases...终止
-
Cancer Targeted TechnologyNational Cancer Institute (NCI); University of California, San Francisco完全的
-
RevimmuneC.R.O. ReSolution Latin America S.A.终止
-
RevimmuneM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Cancer Research Institute... 和其他合作者终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Revimmune撤销
-
RevimmuneWashington University School of Medicine终止
-
RevimmuneUniversity Hospital, Limoges; Amarex Clinical Research终止
-
RevimmuneWashington University School of Medicine; Amarex Clinical Research终止
-
RevimmuneAmarex Clinical Research终止
-
RevimmuneWashington University School of Medicine; Vanderbilt University School of Medicine完全的
-
RevimmuneWashington University School of Medicine; University Hospital, Limoges; George Clinical Pty Ltd终止
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Cancer Immunotherapy Trials Network完全的
-
Cytheris SA未知
-
Newron Pharmaceuticals SPA完全的特发性帕金森病美国, 西班牙, 巴西, 秘鲁, 哥伦比亚, 德国, 阿根廷, 印度, 克罗地亚, 捷克共和国, 意大利, 南非, 芬兰, 葡萄牙, 加拿大, 斯洛伐克, 保加利亚, 智利, 墨西哥, 波兰
-
National Cancer Institute (NCI)主动,不招人晚期膀胱尿路上皮癌 | 晚期输尿管尿路上皮癌 | 转移性膀胱尿路上皮癌 | 转移性肾盂尿路上皮癌 | 转移性输尿管尿路上皮癌 | 转移性尿道尿路上皮癌 | 转移性尿路上皮癌 | 复发性膀胱尿路上皮癌 | 复发性肾盂尿路上皮癌 | 复发性输尿管尿路上皮癌 | 复发性尿道尿路上皮癌 | III 期膀胱癌 AJCC v8 | III 期肾盂癌 AJCC v8 | III 期输尿管癌 AJCC v8 | III 期尿道癌 AJCC v8 | IV 期膀胱癌 AJCC v8 | IV 期肾盂癌 AJCC v8 | IV 期输尿管癌 AJCC v8 | IV 期尿道癌 AJCC v8 | IVA 期膀胱癌 AJCC v8 | IVB 期膀胱癌 AJCC v8 | 不可切除的膀胱尿路上皮癌 | 不可切除的肾盂尿路上皮癌 | ...美国